Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ImpediMed, a developer and marketer of medical device systems, and Metagenics, a life sciences company, have signed an agreement to distribute ImpediMed technology in the US and Canada.
Subscribe to our email newsletter
Greg Brown, CEO of ImpediMed, said: “Metagenics has been an outstanding Australian partner using ImpediMed’s body composition analysis devices for several years. This expanded relationship makes sense in light of our mutual focus on addressing wellness and healthier life styles.”
Mike Katke, vice president of medical marketing at Metagenics, said: “We’ve seen the synergies of combining ImpediMed’s products for assessing fat and fluid status with our own research-based health and wellness products and programs, which we market to healthcare professionals. Their scientifically-grounded approach and the reliability and portability of their technology made offering ImpediMed to our customers a simple decision.”